Time to prostate specific antigen (PSA) nadir may predict rapid relapse in men with metastatic castration-resistant prostate cancer (CRPC) receiving docetaxel chemotherapy

✍ Scribed by Thomas, Betsan M.; Smith, Christian; Evans, Jessica; Button, Michael R.; Kumar, Satish; Palaniappan, Nachi; Staffurth, John; Tanguay, Jacob S.; Lester, Jason F.

• Book ID: 121598396
• Publisher: Springer US
• Year: 2013
• Tongue: English
• Weight: 193 KB
• Volume: 30
• Category: Article
• ISSN: 1357-0560
• DOI: 10.1007/s12032-013-0719-0